首页> 外文期刊>Asia Pacific Journal of Medical Toxicology >Snakebite Prognostic Factors: Leading Factors of Weak Therapeutic Response Following Snakebite Envenomation
【24h】

Snakebite Prognostic Factors: Leading Factors of Weak Therapeutic Response Following Snakebite Envenomation

机译:蛇咬伤的预后因素:蛇咬毒化后治疗反应较弱的主导因素

获取原文
           

摘要

Background: The goal of antivenom administration for snake-bitten patients is to achieve therapeutic response (initial control), which means reversal of the venom-induced effects through neutralizing the venom. The aim of this study was to identify snakebite prognostic factors of weak therapeutic response prior to antivenom administration. Methods: This was a retrospective study of patients with viperidae snakebite envenomation who were admitted to Mashhad Toxicology Centre during 2007-2011. Demographic features, clinical manifestations and snakebite severity score (SSS) were collected prior to antivenom administration. Total number of antivenom vials administered to achieve therapeutic response and duration of hospitalization were also recorded. Potential factors in snakebite prognosis were analyzed by comparing in two groups of achieving therapeutic response with less than 5 vials and over 5 to calculate odds ratio. Results: Total of 108 patients (male/female: 85/23) with mean (SD) age of 34.5 (17.0) were studied. The most common manifestations included fang marks (100%), pain (100%), ecchymosis (89%), swelling (83%), blister formation (48%) and thrombocytopenia (25%). In univariate analysis, thrombocytopenia (P=0.01), spontaneous bleeding (P=0.02), coagulopathic disturbances (P=0.007), swelling (P=0.003), progressive swelling (P=0.005), ecchymosis (P=0.05) and respiratory distress (P= 0.05) were significantly correlated to weak therapeutic response. Swelling and spontaneous bleeding were the strongest snakebite prognostic factors, as respectively they put the patients at 12.4 and 10.4 fold risks for difficult achievement of therapeutic response. Conclusions: In snakebite, some clinical manifestations in the first hours of admission and prior to antivenom administration are associated with weak therapeutic response. Identifying these prognostic factors, can assist health care providers to better estimate the patient’s needs and predict the final consequences.
机译:背景:对被蛇咬伤的患者进行抗蛇毒毒素给药的目的是实现治疗反应(初始控制),这意味着通过中和毒液来逆转毒液诱导的作用。这项研究的目的是在抗蛇毒毒素给药前确定治疗反应较弱的蛇咬预后因素。方法:这是一项回顾性研究,研究对象是2007年至2011年间进入Mashhad毒理学中心的蛇毒蛇咬咬毒症患者。在给予抗蛇毒血清之前收集了人口统计学特征,临床表现和蛇咬严重程度评分(SSS)。还记录了达到治疗反应所需的抗蛇毒药小瓶总数和住院时间。通过比较两组少于5个小瓶和大于5个小瓶的治疗效果来分析蛇咬预后的潜在因素,以计算比值比。结果:共研究了108例患者(男性/女性:85/23),平均(SD)年龄为34.5(17.0)。最常见的表现包括齿痕(100%),疼痛(100%),瘀斑(89%),肿胀(83%),水疱形成(48%)和血小板减少症(25%)。在单变量分析中,血小板减少症(P = 0.01),自发性出血(P = 0.02),凝血功能障碍(P = 0.007),肿胀(P = 0.003),进行性肿胀(P = 0.005),瘀斑(P = 0.05)和呼吸道窘迫(P = 0.05)与弱治疗反应显着相关。肿胀和自发性出血是最强的蛇咬伤预后因素,因为它们分别使患者难以实现治疗反应的风险为12.4和10.4倍。结论:在蛇咬伤中,入院初期和抗蛇毒血清给药前的某些临床表现与较弱的治疗反应有关。识别这些预后因素,可以帮助医疗保健提供者更好地估计患者的需求并预测最终结果。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号